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Abstract:
Oral squamous cell carcinoma (OSCC) is a significant cause of morbidity 
and mortality worldwide, and accounts for the majority of head and neck 
cancers. Metastasis of primary tumours, primarily to cervical lymph 
nodes in the neck, is associated with worsening prognosis. Furthermore, 
the prognosis of patients with extranodal extension of metastatic tumour 
from the lymph nodes into the neck tissues is particularly poor. The 
factors affecting this process are poorly understood and detection is 
difficult pre-surgery. 
Mounting evidence shows that components of the tumour 
microenvironment including cancer-associated fibroblasts, vascular and 
lymphatic endothelial cells, the extracellular matrix and inflammatory 
immune cells, are important modulators of tumour behaviour in primary 
OSCC and other cancers. However, little is known about the lymph node 
microenvironment, its response to tumour presence and role in 
extranodal extension. In addition, there are many lymph node-specific 
cell types and structures, such as fibroblast reticular cells and high 
endothelial venules, making the lymph node microenvironment distinct 
from that found at primary tumour sites, and which contribute to the 
nodal response to tumour presence. 
This review details the current knowledge regarding the lymph node 
tumour microenvironment in OSCC and its role in lymph node metastasis 
and extranodal extension, and relates this to features of the primary 
tumour . Understanding the role that the lymph node microenvironment 
plays in promoting tumour development and extranodal extension may 
aid the identification of novel biomarkers and alternative treatment 
strategies to improve the prognosis of patients with advanced OSCC.
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 Abstract
Oral squamous cell carcinoma (OSCC) is a significant cause of morbidity and 
mortality worldwide, and accounts for the majority of head and neck cancers. Metastasis of 
primary tumours, primarily to cervical lymph nodes in the neck, is associated with worsening 
prognosis. Furthermore, the prognosis of patients with extranodal extension of metastatic 
tumour from the lymph nodes into the neck tissues is particularly poor. The factors affecting 
this process are poorly understood and detection is difficult pre-surgery.
Mounting evidence shows that components of the tumour microenvironment 
including cancer-associated fibroblasts, vascular and lymphatic endothelial cells, the 
extracellular matrix and inflammatory immune cells, are important modulators of tumour 
behaviour in primary OSCC and other cancers. However, little is known about the lymph 
node microenvironment, its response to tumour presence and role in extranodal extension. 
In addition, there are many lymph node-specific cell types and structures, such as fibroblast 
reticular cells and high endothelial venules, making the lymph node microenvironment 
distinct from that found at primary tumour sites, and which contribute to the nodal response 
to tumour presence.
This review details the current knowledge regarding the lymph node tumour 
microenvironment in OSCC and its role in lymph node metastasis and extranodal extension, 
and relates this to features of the primary tumour . Understanding the role that the lymph 
node microenvironment plays in promoting tumour development and extranodal extension 
may aid the identification of novel biomarkers and alternative treatment strategies to improve 
the prognosis of patients with advanced OSCC.
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Introduction 
Oral cancer is the 13th most common cause of cancer mortality in the world1; survival rates 
remain static at 50% and mortality rates are projected to increase due to rising incidence2. 
Oral squamous cell carcinoma (OSCC), which originates from the squamous epithelial cells 
of the oral cavity, is the most common form of oral cancer. However, in comparison to other 
common cancers, the molecular landscape of OSCC is poorly understood, hampering the 
development of novel treatments and prognosticators informing treatment options. In 
particular, successful treatment of OSCC is impeded by its propensity to metastasise to 
locoregional sites such as the cervical lymph nodes and the development of extranodal 
extension (ENE). 
1. Lymph node metastasis
Metastasis of OSCC, usually to the cervical lymph nodes, worsens prognosis3,4. In some 
instances, the metastatic tumour can grow and infiltrate beyond the lymph node capsule and 
invade into the surrounding adipose tissue and muscle. This phenomenon, previously 
referred to as extracapsular spread (ECS), but now renamed extranodal extension (ENE) 
and results in a further significant reduction in prognosis (section 2.1).
OSCC is most commonly treated by surgery with or without radiotherapy or chemotherapy5. 
Owing to the high mortality rate associated with lymph node metastasis, identification of 
patients with node involvement is essential to guide treatment strategies. Currently, fine 
needle aspiration, core biopsies, ultrasound or magnetic resonance imaging (MRI) scanning 
and sentinel node biopsies are used to identify patients with lymph node involvement. 
However, evidence suggests these methods are not sufficiently sensitive6,7 and the risks 
associated with false negative reporting result in a large number of patients undergoing 
elective neck dissections despite being classified as negative for metastatic tumour clinically.  
Only approximately 30% of node-negative patients undergoing elective neck dissection are 
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found to have lymph node involvement8. Although identification and removal of positive 
nodes confers a survival benefit8, a large number of neck dissections - and resulting 
profound morbidity - are unnecessary. Neck dissection may result in neck stiffness and 
constriction, pain, numbness and damage to the spinal accessory nerve which can impair 
shoulder function9.
1.1. Lymph node structure
The lymph node structure and constituent cells play a key role in the colonisation, growth 
and local invasion of OSCC tumours. The highly organised lymph node structure (Figure 1) 
facilitates interactions between cells of the immune system and foreign antigens. In normal 
function, lymph fluid drained from surrounding tissues enters the lymph node via the afferent 
lymph vessels along with circulating antigen presenting cells (APCs). Here the subcapsular 
sinus forms a barrier to fluid entering the lymph node but APCs are able to actively cross it 
along with their antigen cargo10. Fluid containing small antigens and chemokines are 
transported around the lymph node via collagen conduits formed and covered by fibroblast 
reticular cells (FRCs)11. A fibrocollagenous capsule surrounds the entire lymph node and 
supports its structure.
Lymphocytes are organised into distinct compartments in the cortical areas due to 
homeostatic chemokine expression by FRCs. B lymphocytes are localised to B cell follicles 
in the outer cortex, whereas T lymphocytes are located in the inner paracortical areas. Naïve 
lymphocytes enter from blood vessels via the high endothelial venules and lymph fluid and 
lymphocytes are drained from the lymph node via the efferent lymph vessels10.
The complexity of the lymph node stroma was highlighted in a recent comprehensive paper 
which identified nine distinct subsets of non-endothelial stromal cells based on single cell 
RNA-seq data from mouse lymph nodes12. This included several subsets of FRCs and 
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emphasizes the importance of considering the lymph node as a distinct tumour 
microenvironment compared to that found in the oral cavity.
 1.2. Metastatic lymph node tumour development
The routes of lymph node entry used by immune cells are also exploited by tumour cells. 
This is particularly key in OSCC as oral structures (in particular lateral tongue, a common 
site for OSCC) have abundant superficial lymphatic vessels. Tumour cells invading 
lymphatic vessels follow the path of natural lymph drainage, entering the lymph node via the 
afferent lymph vessels and collecting at the subcapsular sinus13 (Figure 1). Complementary 
chemokine expression by tumour cells and the lymphatic endothelial cells lining the 
subcapsular sinus may facilitate tumour migration into the cortex14. Once within the cortex,  
tumour cells proliferate, develop a blood vessel network and, in some cases, generate a 
supportive stroma. Cancer cells can migrate and invade through lymph node tissue and 
break out of the capsule surrounding the lymph node in a process termed ENE (Figure 2). 
2. Extranodal Extension (ENE)
2.1. Prognostic value of ENE
ENE (or ECS) is a key indicator of poor survival, increased recurrence and increased rate of 
distant metastasis4,1517. Shaw et al. (2010)4 reported 5-year survival rates of 65%, 52% and 
23% in node negative, node-positive ENE-negative and node-positive ENE-positive patients, 
respectively. Additionally, a recent study showed that when ENE was categorised based on 
the level of invasion out of the lymph node, patients with the highest level of invasion had a 
significantly poorer survival and higher recurrence rate18. Although by using retrospective 
data these studies do not represent the impact of current treatment strategies, they do 
provide evidence that ENE is a crucial prognostic indicator. This is further highlighted by the 
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recent update to TNM classification, which recommends taking ENE into consideration for 
the tumour to be up-staged.
 2.2. ENE detection
Currently, the presence of ENE is confirmed histologically (Figure 2) following lymph node 
removal through a selective (or in some cases radical) neck dissection. Preoperative 
scanning techniques such as computed tomography (CT) and MRI are also used for ENE 
diagnosis. However, a recent meta-analysis revealed that the mean sensitivity and specificity 
of these methods is below 0.85, meaning that a significant proportion of patients are still 
being misdiagnosed19. This false negative reporting could delay identification of patients 
requiring more aggressive treatment. There have been reports of primary tumour gene 
expression signatures that can predict ENE2022; which would aid treatment decisions but 
larger studies are needed before translation to the clinic can be considered.
In order to develop more effective diagnostic and therapeutic tools, the mechanisms of ENE 
need to be better understood, both within the tumour and its surrounding environment.
 
3. The tumour microenvironment in ENE
The behaviour of cancer cells is heavily influenced by the multitudinous cell types present in 
the tumour microenvironment (TME, Figure 3). Fibroblasts, lymphatic and vascular 
endothelial cells, and inflammatory immune cells are all key components of the TME and are 
able to influence cancer development through multiple intercellular signalling pathways and 
their influence on the extracellular matrix (ECM). There has been increased focus on the 
OSCC TME in recent years and it has been proposed that it may be a key driver of lymph 
node metastasis and ENE.
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3.1. Cancer-associated fibroblasts
Cancer-associated fibroblasts (CAF) are often found surrounding epithelial tumour islands 
and contribute to cancer progression through the secretion of a range of growth factors, 
proteases and cytokines, as well as contributing to the development of a tumour-permissive 
ECM. The myofibroblast marker E4! muscle actin /E$0 is often used as a CAF 
marker, but evidence suggest that the CAF population is very heterogeneous and other CAF 
phenotypes, such as senescent CAF, are also important23. Single-cell transcriptome analysis 
of a set of matched primary and lymph node OSCC tumours identified several subsets of 
CAF which were present at both sites, but in varying proportions and with differential 
expression of certain ligands and receptors at each site24. This may indicate that CAF 
populations are maintained following metastasis but that the lymph node signalling 
environment alters their composition. Many alternative CAF sources including recruited 
mesenchymal stem cells, resident fibroblasts and differentiated epithelial cancer cells have 
been suggested25 but the exact origins and mechanisms by which CAF are generated in the 
lymph node are yet to be fully elucidated .
In OSCC, the presence of E$4+!
 CAF in the tumour stroma has been linked to poor 
survival, increased recurrence, lymph node metastasis and increased ENE2628. E$4
positive fibroblasts are also present in lymph node tumours and unpublished data from our 
lab has shown that they are more abundant in nodes with ENE as well as their matched 
primary tumours and the presence of a more desmoplastic stroma in ENE-positive nodes 
(Figure 4). 
CAF have been linked to the promotion of migration, invasion and metastasis in primary 
tumour OSCC both in vitro and ex vivo. However, their influence on ENE is less well 
understood. The development of a mesenchymal phenotype in cancer cells through a 
process called epithelial-mesenchymal transition (EMT) is a key route through which cancer 
cells gain the ability to migrate and invade and this has been proposed as a possible 
mechanism behind ENE. Puram et al. (2017) identified a partial-EMT expression signature 
Page 8 of 22Journal of Oral Pathology and Medicine - Proof for Peer Review
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review
 O
nly
which localised to the leading edge of tumour islands in both primary and lymph node 
OSCC24. These islands were also surrounded by CAF which were enriched for EMT-
promoting ligands. Lee et al. (2014) investigated EMT marker expression in lymph nodes 
with and without ENE29. They found that EMT was a better predictor of poor survival than 
ENE alone as ENE-positive patients with a high percentage of tumour cells expressing 
mesenchymal markers had a five times worse survival rate compared to ENE-negative 
patients. 
Together, these studies provide evidence that CAF might be important in ENE development 
but further work is needed to elucidate the mechanisms by which they influence tumour 
development.
3.2. Fibroblast reticular cells
Fibroblast reticular cells (FRCs) are a specialised sub-type of fibroblasts found within the 
lymph node (Figure 1). FRCs produce complex networks of collagen conduits ensheathed in 
a basement membrane which provide structure and support to the lymph node. These 
conduits transport fluid containing chemokines and small antigens through the lymph node to 
the high endothelial venules11. 
Despite their critical role in nodal function, very few studies have investigated the FRC 
response to metastatic cancer.  Riedel et al. (2016)30 investigated FRC responses in the 
tumour draining lymph nodes (TDLN) of a mouse melanoma model. They observed an 
enlargement of pre-metastatic TDLNs which was partly attributed to an expansion of FRCs. 
Whole genome transcriptome analysis comparing non-draining lymph nodes, early and late 
stage TDLNs revealed many alterations in gene expression including an increase in FRC 
activation markers. Most significantly they observed a dysregulation in cytokine and 
chemokine signalling in the late stage nodes which resulted in a disorganised tissue 
architecture and alteration to immune cell composition. Alterations to transporter function, 
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remodelling of collagen fibres and changes to cell junction proteins were also found in late 
stage nodes where conduits were widened. The authors suggested this loss of conduit 
integrity may aid the delivery of tumour-derived factors, debris and antigens deep into the 
lymph node to aid subsequent lymph node metastasis. 
However, the impact of FRCs on tumour cells and their development once they reach the 
lymph node is unknown. In addition, multiple subtypes of FRC have now been identified 
within the lymph node localised to specific areas within the cortex or subcapsular synapse12, 
suggesting that more detailed analysis of FRC subset responses may be needed to 
understand their role in the different stages of lymph node metastases development.
 
3.3. Extracellular matrix
The extracellular matrix (ECM) provides a supportive structure to all tissues. It is formed of 
fibrous proteins, such as collagen and fibronectin, and glycosaminoglycans, predominantly 
secreted by fibroblasts31. Fibroblasts also secrete enzymes such as matrix 
metalloproteinases which cleave ECM proteins, allowing for structural remodelling or the 
release of bound signalling molecules31. The ECM plays an important role in cancer 
development, particularly as cancer cells must migrate along and invade through the ECM if 
they are to metastasise to other sites. In lymph nodes FRCs are the key secretors of the 
ECM, which is primarily made up of collagen conduits (section 3.2). 
Although altered ECM composition has been reported in OSCC31, data is scarce regarding 
the response of the lymph node ECM to cancer presence. Rizwan et al. (2015)32 
investigated collagen density using a mouse model of metastatic breast cancer and found 
that lymph nodes containing metastatic deposits had a higher collagen I density compared to 
mice with non-metastatic breast cancer or no tumour. They also examined human breast 
cancer lymph nodes with metastasis and saw an up-regulation of collagen and fibronectin 
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compared to tumour-free lymph nodes. The contribution of ECM alterations, both in terms of 
composition and physical properties, to ENE remains to be determined.
 
3.4. Lymphatic and vascular endothelial cells
Endothelial cells line blood and lymphatic vessels, both of which are important in facilitating 
tumour growth as well as providing a route of metastasis. In OSCC, increased vascular and 
lymphatic invasion has been linked to increased nodal metastasis and ENE33,34. Increased 
vessel density and elevated expression of pro-angiogenic factors have been observed in 
primary OSCC and correlated with increased lymph node metastasis35,36, decreased 
survival36,37, and elevated levels of E$4+!
 CAF38. However, few studies focus on the 
role of endothelial cells within the lymph node.
A study using an OSCC mouse model found that blood vessel density was elevated in 
tumour-draining lymph nodes when metastatic, but not non-metastatic, tumour cells were 
implanted into the tongue, suggesting the lymph node TME is altered prior to colonisation39. 
Furthermore, in a mouse model of squamous cell carcinoma, metastasising tumour cells 
were observed accumulating around blood vessels in the lymph node cortex and moving 
inside the vessel lumen40. This study therefore proposed that blood vessels may be an 
important route of further metastasis from the lymph node.
In lymph nodes, specialised blood vessels called high endothelial venules (HEV) are found 
in the paracortex, formed of cuboidal endothelial cells surrounded by FRCs (Figure 1). In 
OSCC lymph nodes with metastatic deposits, an increased density of HEVs has been 
observed and correlated to poor prognosis41. However, HEV density has also been found to 
be elevated during lymph node enlargement prior to metastatic colonisation42 and in sentinel 
lymph nodes (SLN) regardless of metastatic status compared to non-SLNs43. Furthermore, 
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tumour deposits have been observed adjacent to HEVs suggesting this may be an 
alternative route for metastasis42.
The response of lymphatic vessels to tumour presence in the lymph node is not clear. Chung 
et al. (2012) reported an increase in lymphatic vessel density in SLNs regardless of 
metastasis status compared to non-SLN43, whereas Wakisaka et al. (2015) found that the 
density was significantly higher in SLN with metastatic deposits compared to tumour-free 
SLN44. 
Research so far has focussed on the angiogenic response of the lymph node prior and 
immediately following colonisation; further work is needed to elucidate the role of endothelial 
cells in ENE.
3.5. Inflammation and tumour-associated macrophages
The generation of an inflammatory microenvironment is now known to be a crucial driver of 
tumour progression. The innate immune cells crucial to this inflammatory response, including 
macrophages and neutrophils, have multitudinal effects on the tumour and its 
microenvironment through their secretion of cytokines, chemokines, prostaglandins and 
other factors45. The response of both native and recruited immune cells to tumour presence 
in the lymph node is an important consideration and may impact on ECS development.
Macrophages are recruited to the tumour in response to a variety of signals secreted by 
tumour and stromal cells. Aberrant chemokine signalling in FRCs in response to the cancer 
presence has been shown to increase macrophage presence in lymph nodes in a mouse 
model of metastatic melanoma30. Macrophages can display diverse behaviours, with some 
contributing to an active inflammatory immune response while others, often labelled M2 
macrophage, are anti-inflammatory and promote tissue remodelling and repair in healthy 
tissues46. Tumour-associated macrophages (TAMs), which display M2 phenotype behaviour, 
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are able to aid tumour progression through the stimulation of proliferation, angiogenisis, and 
ECM remodelling and the suppression of anti-tumour immunity46.
In primary OSCC, high macrophage numbers have been linked to poor prognosis and 
increased lymph node metastasis4749. However, there is some disagreement as to whether 
macrophage densities in the tumour, invasive edge or stroma are significant and whether 
this association is only found when staining for M2 macrophage markers. Only one study, to 
our knowledge, has investigated macrophage in metastatic lymph nodes of OSCC50. 
However, this focussed on whether macrophage numbers or polarisation in the lymph node 
sinus could predict primary tumour invasion and grading parameters, with results varying 
depending on the macrophage marker ratio used. 
4. Perspectives and clinical impact
This review provides an overview of current knowledge regarding the development and 
treatment of lymph node metastasis and ENE in OSCC, and the role of the TME in these 
processes. There is mounting evidence that the TME has the ability to induce the invasion 
and metastasis of primary tumour OSCC and evidence is beginning to emerge to link the 
TME to lymph node tumour development. However, direct evidence and specific 
mechanisms of action are lacking and many questions remain unanswered including the 
origin of lymph node-associated CAFs and the response of the many resident immune cells 
to the presence of metastatic deposits. Advances in in vitro cell culture techniques, such as 
3D modelling of lymph nodes, combined with in vivo and ex vivo data may help reveal the 
molecular and cellular mechanisms underlying ENE.
 Given their importance, it is not surprising that therapeutic targeting of many of the 
TME cell types and ENE is seen as a promising approach. The greater genetic stability and 
influence CAFs, TAMs, FRCs and endothelial cells have on the ECM, which is often a barrier 
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for the delivery of drugs to solid tumours, makes them even more attractive. Given the 
difficulties faced in the detection of ENE pre-surgery, the huge quality of life impact on 
patients and economic cost of unnecessary neck dissections, the TME also represents a 
promising area for the identification of novel prognostic biomarkers for use either in primary 
tumour samples or lymph node biopsies. Understanding the ENE process and the 
mechanisms underpinning it could have a significant impact on prognostic and therapeutic 
tools available to clinicians treating OSCC patients.
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Figure legends
 
Figure 1: Structure of the lymph node and infiltration by tumour cells. Cancer cells 
enter the lymph node via afferent lymph vessels along with antigen presenting cells. The 
subcapsular sinus prevents fluid from entering the cortical areas but allows active cellular 
transport, including that of cancer cells. Macrophages in the subcapsular sinus are capable 
of sampling large antigens for presentation to B cells. B cell zones are found in the cortex 
along with follicular dendritic cells (FDC) which form a supportive network, and secrete a 
wide range of immune cell modulators with T cells contained with the paracortex. Collagen 
conduits formed by fibroblastic reticular cells (FRC) carry fluid around the lymph node and 
blood vessels carrying naïve lymphocytes enter via the high endothelial venules (HEV) in the 
paracortex. Lymph fluid is drained from the node via the efferent lymph vessels.
Figure 2: Histological images of lymph node metastasis and extranodal extension. 
Lymph node OSCC tumour specimens stained with haemotoxylin and eosin (H&E) showing 
metastatic deposits without (top) and with (bottom) extranodal extension.  
 
Figure 3: Cells and components of the tumour microenvironment (TME). Malignant 
epithelial cancer cells are supported by a number of stromal cells that make up the TME. 
Cancer associated fibroblasts (CAFs) promote tumour development through the secretion of 
a range of growth factors, proteases and cytokines as well as secreting and remodelling the 
extracellular matrix (ECM). Blood and lymphatic vessels are important structures in the TME 
and represent key routes of metastasis. Tumour cells, alongside CAFs, recruit inflammatory 
innate immune cells to the tumour site, such as tumour-associated macrophage (TAMs). 
TAMs themselves are able to promote tumour growth, vessel formation and ECM modulation 
as well as inhibiting anti-tumour immune responses.
Figure 4: Immunohistochemical staining of 1*		 muscle actin #1/"% in ENE-
positive patient tissue specimens. Immunohistochemical staining of T$ in primary 
tumour (left) and lymph node tumour (right) ENE-positive OSCC patient tissue specimens 
showing T$4+!
 stroma surrounding tumour islands. x10 magnification, scale bars 
200 µm.
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Figure 2: Histological images of lymph node metastasis and extranodal extension. Lymph node OSCC 
tumour specimens stained with haemotoxylin and eosin (H&E) showing metastatic deposits without (top) 
and with (bottom) extranodal extension.   
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Figure 4: Immunohistochemical staining of -smooth muscle actin (SMA) in EN ive patient tissue 
specimens. Immunohistochemical staining o SM in primar tumour  	
o and 	 node tumour (right) 
ENEv
 eSCC patient tissue specimens showing SMve stroma surrounding tumour islands. x10 
magnioication le bars 200 µ 
1788

m (150 x 150 DPI) 
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